- Home
- JAZZ vs TPG Comparison
JAZZ vs TPG Comparison
Compare JAZZ & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- TPG
- Stock Information
- Founded
- JAZZ 2003
- TPG 1992
- Country
- JAZZ Ireland
- TPG United States
- Employees
- JAZZ N/A
- TPG N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- TPG Investment Managers
- Sector
- JAZZ Health Care
- TPG Finance
- Exchange
- JAZZ Nasdaq
- TPG Nasdaq
- Market Cap
- JAZZ 8.2B
- TPG 8.2B
- IPO Year
- JAZZ 2007
- TPG 2022
- Fundamental
- Price
- JAZZ $141.45
- TPG $57.88
- Analyst Decision
- JAZZ Strong Buy
- TPG Buy
- Analyst Count
- JAZZ 14
- TPG 14
- Target Price
- JAZZ $179.71
- TPG $65.62
- AVG Volume (30 Days)
- JAZZ 739.6K
- TPG 2.1M
- Earning Date
- JAZZ 11-05-2025
- TPG 11-04-2025
- Dividend Yield
- JAZZ N/A
- TPG 3.02%
- EPS Growth
- JAZZ N/A
- TPG N/A
- EPS
- JAZZ N/A
- TPG 0.10
- Revenue
- JAZZ $4,157,832,999.00
- TPG $4,255,344,000.00
- Revenue This Year
- JAZZ $5.80
- TPG N/A
- Revenue Next Year
- JAZZ $6.06
- TPG $24.79
- P/E Ratio
- JAZZ N/A
- TPG $591.13
- Revenue Growth
- JAZZ 4.14
- TPG 24.91
- 52 Week Low
- JAZZ $95.49
- TPG $37.52
- 52 Week High
- JAZZ $148.06
- TPG $72.98
- Technical
- Relative Strength Index (RSI)
- JAZZ 61.16
- TPG 55.67
- Support Level
- JAZZ $128.80
- TPG $54.54
- Resistance Level
- JAZZ $144.97
- TPG $59.25
- Average True Range (ATR)
- JAZZ 4.65
- TPG 1.84
- MACD
- JAZZ -0.13
- TPG 0.46
- Stochastic Oscillator
- JAZZ 75.14
- TPG 81.61
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.